JP2016008188A - Skin texture improving agent, epidermis turnover improving agent, epidermis barrier function improving agent, antioxidant, and external preparation for skin - Google Patents
Skin texture improving agent, epidermis turnover improving agent, epidermis barrier function improving agent, antioxidant, and external preparation for skin Download PDFInfo
- Publication number
- JP2016008188A JP2016008188A JP2014128848A JP2014128848A JP2016008188A JP 2016008188 A JP2016008188 A JP 2016008188A JP 2014128848 A JP2014128848 A JP 2014128848A JP 2014128848 A JP2014128848 A JP 2014128848A JP 2016008188 A JP2016008188 A JP 2016008188A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- improving agent
- epidermis
- glyceryl
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 19
- 230000037365 barrier function of the epidermis Effects 0.000 title claims abstract description 12
- 210000003491 skin Anatomy 0.000 title claims abstract description 12
- 230000007306 turnover Effects 0.000 title claims abstract description 12
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 11
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 210000002615 epidermis Anatomy 0.000 title claims abstract description 8
- 230000036548 skin texture Effects 0.000 title abstract description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 50
- 239000000194 fatty acid Substances 0.000 claims abstract description 50
- 229930195729 fatty acid Natural products 0.000 claims abstract description 50
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 48
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000000787 lecithin Substances 0.000 claims abstract description 17
- 235000010445 lecithin Nutrition 0.000 claims abstract description 17
- 229940067606 lecithin Drugs 0.000 claims abstract description 17
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 14
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 14
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940032094 squalane Drugs 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- -1 fatty acid triglycerides Chemical class 0.000 claims description 15
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 claims description 14
- 235000013871 bee wax Nutrition 0.000 claims description 13
- 239000012166 beeswax Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 229940092738 beeswax Drugs 0.000 claims description 4
- 230000014509 gene expression Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 2
- 230000033444 hydroxylation Effects 0.000 abstract 2
- 238000005805 hydroxylation reaction Methods 0.000 abstract 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000007766 cera flava Substances 0.000 abstract 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 15
- 239000012071 phase Substances 0.000 description 15
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 14
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 14
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000008117 stearic acid Substances 0.000 description 8
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 7
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 7
- KHAVLLBUVKBTBG-UHFFFAOYSA-N dec-9-enoic acid Chemical compound OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 7
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 229960002446 octanoic acid Drugs 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 5
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- 241000772415 Neovison vison Species 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 3
- 239000005639 Lauric acid Substances 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 3
- 240000000912 Macadamia tetraphylla Species 0.000 description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000004433 Simmondsia californica Nutrition 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000003346 palm kernel oil Substances 0.000 description 3
- 235000019865 palm kernel oil Nutrition 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- MBXVIRZWSHICAV-UHFFFAOYSA-N Glycerol triundecanoate Chemical compound CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCC)COC(=O)CCCCCCCCCC MBXVIRZWSHICAV-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N Myristoleic acid Natural products CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 235000012716 cod liver oil Nutrition 0.000 description 2
- 239000003026 cod liver oil Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 229960002703 undecylenic acid Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical class CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- ZUUFLXSNVWQOJW-MBIXAETLSA-N (2e,4e,6e)-octadeca-2,4,6-trienoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C(O)=O ZUUFLXSNVWQOJW-MBIXAETLSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- PAWGRNGPMLVJQH-UHFFFAOYSA-N (E)-2-Dodecenoic acid Natural products CCCCCCCCCC=CC(O)=O PAWGRNGPMLVJQH-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZVRMGCSSSYZGSM-CCEZHUSRSA-N (E)-hexadec-2-enoic acid Chemical compound CCCCCCCCCCCCC\C=C\C(O)=O ZVRMGCSSSYZGSM-CCEZHUSRSA-N 0.000 description 1
- PJHOFUXBXJNUAC-KTKRTIGZSA-N (Z)-hexadec-7-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCC(O)=O PJHOFUXBXJNUAC-KTKRTIGZSA-N 0.000 description 1
- IJBFSOLHRKELLR-BQYQJAHWSA-N (e)-dodec-5-enoic acid Chemical compound CCCCCC\C=C\CCCC(O)=O IJBFSOLHRKELLR-BQYQJAHWSA-N 0.000 description 1
- YZAZXIUFBCPZGB-FJEDDJBMSA-N (e)-octadec-9-enoic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O.CCCCCCCC\C=C\CCCCCCCC(O)=O YZAZXIUFBCPZGB-FJEDDJBMSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- JHULURRVRLTSRD-UHFFFAOYSA-N 1-cyclohexylpyrrolidine-2,5-dione Chemical compound O=C1CCC(=O)N1C1CCCCC1 JHULURRVRLTSRD-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- GKLLDHHZSUEWRE-UHFFFAOYSA-N 2,3-bis(18-acetyloxyoctadecanoyloxy)propyl 18-acetyloxyoctadecanoate Chemical compound CC(=O)OCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCOC(C)=O)COC(=O)CCCCCCCCCCCCCCCCCOC(C)=O GKLLDHHZSUEWRE-UHFFFAOYSA-N 0.000 description 1
- RIXCYAQOGLLEIU-UINBUCCLSA-N 2,3-bis[[(z,12r)-12-acetyloxyoctadec-9-enoyl]oxy]propyl (z,12r)-12-acetyloxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](OC(C)=O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C[C@@H](CCCCCC)OC(C)=O)COC(=O)CCCCCCC\C=C/C[C@@H](CCCCCC)OC(C)=O RIXCYAQOGLLEIU-UINBUCCLSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AFGUVBVUFZMJMX-MDZDMXLPSA-N 5-Tetradecenoic acid Chemical compound CCCCCCCC\C=C\CCCC(O)=O AFGUVBVUFZMJMX-MDZDMXLPSA-N 0.000 description 1
- NNNVXFKZMRGJPM-ZHACJKMWSA-N 7-Palmitoleic acid Chemical compound CCCCCCCCC\C=C\CCCCC(O)=O NNNVXFKZMRGJPM-ZHACJKMWSA-N 0.000 description 1
- OYHQOLUKZRVURQ-UHFFFAOYSA-N 9,12-Octadecadienoic Acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241000358061 Apis cerana indica Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 229920006051 Capron® Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- JJOJFIHJIRWASH-UHFFFAOYSA-N Eicosanedioic acid Natural products OC(=O)CCCCCCCCCCCCCCCCCCC(O)=O JJOJFIHJIRWASH-UHFFFAOYSA-N 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- MTUBBMSQXXJFQP-UHFFFAOYSA-N OC(CCCCCCCCCCCCCCCCC(=O)OCC(O)CO)(O)O Chemical compound OC(CCCCCCCCCCCCCCCCC(=O)OCC(O)CO)(O)O MTUBBMSQXXJFQP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- CNVZJPUDSLNTQU-UHFFFAOYSA-N Petroselaidic acid Natural products CCCCCCCCCCCC=CCCCCC(O)=O CNVZJPUDSLNTQU-UHFFFAOYSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 241000221095 Simmondsia Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- QDRSJFZQMOOSAF-IHWYPQMZSA-N cis-9-undecenoic acid Chemical compound C\C=C/CCCCCCCC(O)=O QDRSJFZQMOOSAF-IHWYPQMZSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- HABLENUWIZGESP-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O HABLENUWIZGESP-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- ZJVATSUMFCZSKA-KVVVOXFISA-N docos-13-enoic acid;(z)-docos-13-enoic acid Chemical compound CCCCCCCCC=CCCCCCCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O ZJVATSUMFCZSKA-KVVVOXFISA-N 0.000 description 1
- AGDANEVFLMAYGL-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCC(O)=O AGDANEVFLMAYGL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- NSEXTLCTTCFJCT-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCC(O)=O NSEXTLCTTCFJCT-UHFFFAOYSA-N 0.000 description 1
- KYYWBEYKBLQSFW-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O KYYWBEYKBLQSFW-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-AVQMFFATSA-N linoelaidic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CHWMPPNDIBLYMB-UHFFFAOYSA-N n',n'-bis(prop-2-enyl)ethane-1,2-diamine Chemical compound NCCN(CC=C)CC=C CHWMPPNDIBLYMB-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- RQFLGKYCYMMRMC-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O RQFLGKYCYMMRMC-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- CNVZJPUDSLNTQU-OUKQBFOZSA-N petroselaidic acid Chemical compound CCCCCCCCCCC\C=C\CCCCC(O)=O CNVZJPUDSLNTQU-OUKQBFOZSA-N 0.000 description 1
- CNVZJPUDSLNTQU-SEYXRHQNSA-N petroselinic acid Chemical compound CCCCCCCCCCC\C=C/CCCCC(O)=O CNVZJPUDSLNTQU-SEYXRHQNSA-N 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000005472 straight-chain saturated fatty acid group Chemical group 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- AFGUVBVUFZMJMX-UHFFFAOYSA-N trans 5-tetradecenoic acid Natural products CCCCCCCCC=CCCCC(O)=O AFGUVBVUFZMJMX-UHFFFAOYSA-N 0.000 description 1
- PAWGRNGPMLVJQH-ZHACJKMWSA-N trans-2-dodecenoic acid Chemical compound CCCCCCCCC\C=C\C(O)=O PAWGRNGPMLVJQH-ZHACJKMWSA-N 0.000 description 1
- DPUOLQHDNGRHBS-MDZDMXLPSA-N trans-Brassidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-MDZDMXLPSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-VBJOUPRGSA-N triricinolein Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC)COC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-VBJOUPRGSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、水酸化レシチンを有効成分とする、肌理改善剤、表皮ターンオーバー改善剤、表皮バリア機能改善剤、抗酸化剤、及び皮膚外用剤に関する。 The present invention relates to a skin texture improving agent, an epidermis turnover improving agent, an epidermis barrier function improving agent, an antioxidant, and an external preparation for skin, containing hydroxy lecithin as an active ingredient.
水酸化レシチンを含有する化粧料は、安全性、保湿性、感触性に優れることが知られている(特許文献1特開平6−116116号公報)。
ヒトは加齢により、表皮ターンオーバーの鈍化、表皮バリア機能の低下、抗酸化機能の低下が認められることが知られている。また、高齢化社会の中で、いつまでも美しくありたいと願う女性の願望は、年々高まっている。そのため、安全性が高く、より高い老化防止、改善効果を有する成分の開発に関するニーズは非常に大きい。
It is known that cosmetics containing hydroxylated lecithin are excellent in safety, moisture retention and touch (Patent Document 1 JP-A-6-116116).
It is known that with human aging, a decrease in epidermal turnover, a decrease in epidermal barrier function, and a decrease in antioxidant function are observed. In addition, in an aging society, the desire of women who want to be beautiful forever is increasing year by year. Therefore, there is a great need for the development of ingredients that are highly safe and have higher aging prevention and improvement effects.
本発明は、表皮ターンオーバー改善関連因子、表皮バリア機能改善関連因子、抗酸化関連因子の発現を促進することにより、安全かつ効率的に肌理を改善し得る素材を提供することを課題とする。 An object of the present invention is to provide a material that can improve the texture safely and efficiently by promoting the expression of an epidermal turnover improvement-related factor, an epidermal barrier function improvement-related factor, and an antioxidant-related factor.
本発明者らは、天然由来の種々の成分について検討を行った結果、水酸化レシチンが、ヒト表皮細胞における、表皮ターンオーバー改善関連因子、表皮バリア機能改善関連因子、抗酸化関連因子の発現を著しく促進することを見出し、本発明を完成させるに至った。 As a result of studying various components derived from the natural environment, the present inventors have found that hydroxylated lecithin can express the expression of epidermal turnover improving factor, epidermal barrier function improving factor, and antioxidant related factor in human epidermal cells. It has been found that it is remarkably accelerated, and the present invention has been completed.
すなわち、本発明は、水酸化レシチンを有効成分とする、肌理改善剤、表皮ターンオーバー改善剤、表皮バリア機能改善剤、抗酸化剤に関する。 That is, the present invention relates to a skin texture improving agent, an epidermis turnover improving agent, an epidermis barrier function improving agent, and an antioxidant, which contain hydroxy lecithin as an active ingredient.
さらに本発明は、水酸化レシチンと、炭素数が10〜22の脂肪酸の1種又は2種以上、脂肪酸トリグリセリドの1種又は2種以上、スクワラン、ミツロウ、及びホホバ油を含有する皮膚外用剤に関する。 Furthermore, the present invention relates to a skin external preparation containing hydroxylated lecithin, one or more fatty acids having 10 to 22 carbon atoms, one or more fatty acid triglycerides, squalane, beeswax, and jojoba oil. .
本発明の肌理改善剤は、表皮における表皮ターンオーバー改善関連因子、表皮バリア機能改善関連因子、抗酸化関連因子の発現を促進することにより、安全かつ効率的に肌理を整える効果を発揮する。 The skin texture-improving agent of the present invention exerts the effect of preparing the texture safely and efficiently by promoting the expression of an epidermis turnover improvement-related factor, an epidermis barrier function improvement-related factor, and an antioxidant-related factor in the epidermis.
水酸化レシチンは、レシチン中の不飽和炭素鎖に水酸基を導入したものである。水酸化大豆レシチン、水酸化卵黄レシチンが例示できる。本発明の効果の点から、水酸化大豆レシチンを用いることが好ましい。 Hydroxy lecithin is a hydroxyl group introduced into an unsaturated carbon chain in lecithin. Examples include hydroxylated soybean lecithin and hydroxylated egg yolk lecithin. From the viewpoint of the effect of the present invention, it is preferable to use hydroxylated soybean lecithin.
本発明の肌理改善剤での有効成分である水酸化レシチンは、炭素数が10〜22の脂肪酸の1種又は2種以上、脂肪酸トリグリセリドの1種又は2種以上、スクワラン、ミツロウ、及びホホバ油を含有する皮膚外用剤に配合することにより、保湿効果が相乗的に向上する。 The lecithin hydroxide, which is an active ingredient in the texture improving agent of the present invention, is one or more fatty acids having 10 to 22 carbon atoms, one or more fatty acid triglycerides, squalane, beeswax, and jojoba oil. The moisturizing effect is synergistically improved by blending with a skin external preparation containing
炭素数が10〜22の脂肪酸としては、デカン酸(カプリン酸),ウンデカン酸,ドデカン酸(ラウリン酸),テトラデカン酸(ミリスチン酸),ペンタデカン酸,ヘキサデカン酸(パルミチン酸),ヘプタデカン酸(マルガリン酸),オクタデカン酸(ステアリン酸),エイコサン酸(アラキン酸),ドコサン酸(ベヘン酸)等の直鎖飽和脂肪酸、9-デセン酸(カプロレイン酸),9-ウンデセン酸(9-ウンデシレン酸),10-ウンデセン酸(10-ウンデシレン酸),2-ドデセン酸(2-ラウロレイン酸),5-ドデセン酸(5-ラウロレイン酸),11-ドデセン酸(11-ラウロレイン酸),5-テトラデセン酸(5-ミリストレイン酸),9-テトラデセン酸(9-ミリストレイン酸),2-ヘキサデセン酸(2-パルミトレイン酸),cis-7-ヘキサデセン酸(7-パルミトレイン酸),cis-6-オクタデセン酸(ペトロセリン酸),trans-6-オクタデセン酸(ペトロセエライジン酸),cis-9-オクタデセン酸(オレイン酸),trans-9-オクタデセン酸(エライジン酸),cis-13-ドコセン酸(エルカ酸),trans-13-ドコセン酸(ブラシン酸)等の直鎖モノエン酸、cis-9-,cis-12-オクタデカジエン酸(リノール酸),trans-9-,trans-12-オクタデカジエン酸(リノエライジン酸)等のジエン酸、cis-9,cis-12,cis-15-オクタデカトリエン酸(リノレン酸),trans-9,trans-12,trans-15-オクタデカトリエン酸(リノレンエライジン酸)等のトリエン酸、イソパルミチン酸,イソステアリン酸等の分岐鎖を有する脂肪酸等が挙げられ、化粧品,医薬品用原料として市販されているものを利用することができる。本発明においては、これらより1種又は2種以上を選択して用いる。本発明の効果の点から、ステアリン酸を用いることが最も好ましい。 Examples of fatty acids having 10 to 22 carbon atoms include decanoic acid (capric acid), undecanoic acid, dodecanoic acid (lauric acid), tetradecanoic acid (myristic acid), pentadecanoic acid, hexadecanoic acid (palmitic acid), heptadecanoic acid (margaric acid) ), Straight-chain saturated fatty acids such as octadecanoic acid (stearic acid), eicosanoic acid (arachinic acid), docosanoic acid (behenic acid), 9-decenoic acid (caproleic acid), 9-undecenoic acid (9-undecylenic acid), 10 -Undecenoic acid (10-undecylene acid), 2-dodecenoic acid (2-laurolenic acid), 5-dodecenoic acid (5-laurolenic acid), 11-dodecenoic acid (11-laurolenic acid), 5-tetradecenoic acid (5- Myristoleic acid), 9-tetradecenoic acid (9-myristoleic acid), 2-hexadecenoic acid (2-palmitoleic acid), cis-7-hexadecenoic acid (7-palmitoleic acid) ), Cis-6-octadecenoic acid (petroceric acid), trans-6-octadecenoic acid (petroceleic acid), cis-9-octadecenoic acid (oleic acid), trans-9-octadecenoic acid (elaidic acid), cis- Linear monoenoic acid such as 13-docosenoic acid (erucic acid), trans-13-docosenoic acid (brassic acid), cis-9-, cis-12-octadecadienoic acid (linoleic acid), trans-9-, trans Dienoic acids such as -12-octadecadienoic acid (linoelaidic acid), cis-9, cis-12, cis-15-octadecatrienoic acid (linolenic acid), trans-9, trans-12, trans-15- Examples include trienoic acids such as octadecatrienoic acid (linolenic elaidic acid), fatty acids having branched chains such as isopalmitic acid, isostearic acid, and the like. Commercially available products for cosmetics and pharmaceuticals can be used. In the present invention, one or more of these are selected and used. From the viewpoint of the effects of the present invention, it is most preferable to use stearic acid.
本発明において用いる脂肪酸トリグリセリドとしては、トリアセチルヒドロキシステアリン酸グリセリル,トリアセチルリシノール酸グリセリル,トリイソステアリン酸グリセリル,トリウンデカン酸グリセリル,トリヒドロキシステアリン酸グリセリル,トリ2-エチルヘキサン酸グリセリル,トリオレイン酸グリセリル,トリ(カプリル・カプリン・イソステアリン・アジピン酸)グリセリル,トリ(カプリル酸・カプリン酸)グリセリル,トリ(カプリル・カプリン・ミリスチン・ステアリン酸)グリセリル,トリ(カプリル・カプリン・ラウリン酸)グリセリル,トリ(カプリル・カプリン・リノール酸)グリセリル,トリカプリル酸グリセリル,トリカプリン酸グリセリル,トリ牛脂脂肪酸グリセリル,トリ(牛脂脂肪酸・ミンク油脂肪酸・タラ肝油脂肪酸)グリセリル,トリステアリン酸グリセリル,トリパルミチン酸グリセリル,トリ2-ヘプチルウンデカン酸グリセリル,トリベヘン酸グリセリル,トリミリスチン酸グリセリル,トリ(ミンク油脂肪酸・パルミチン酸)グリセリル,トリヤシ油脂肪酸グリセリル,トリラウリン酸グリセリル,トリラノリン脂肪酸グリセリル,トリ(リシノレイン・カプロン・カプリル・カプリン酸)グリセリル,トリリノール酸グリセリル、水添トリ脂肪酸(C12−18)グリセリル、(水添ロジン/ジイソステアリン酸)グリセリル、トリ(カプリル酸/カプリン酸/ステアリン酸)グリセリル、トリ(カプリル酸/カプリン酸/ミリスチン酸/ステアリン酸)グリセリル、トリ(カプリル酸/カプリン酸/ラウリン酸)グリセリル、トリ(カプリル酸/カプリン酸/リノール酸)グリセリル、トリ脂肪酸(C10−18)グリセリル、トリ脂肪酸(C12−18)グリセリル、トリ脂肪酸(C12−20)グリセリル、トリ脂肪酸(C18−36)グリセリル、トリ(パーム油脂肪酸/パーム核油脂肪酸/オリーブ油脂肪酸/マカデミアナッツ油脂肪酸/アブラナ種子油脂肪酸)グリセリル、トリ(ヒマシ脂肪酸/オリーブ脂肪酸)グリセリル、トリ分岐脂肪酸(C10−40)グリセリル、トリ分岐脂肪酸(C12−31)グリセリル、トリ(ベヘン酸/イソステアリン酸/エイコサン二酸)グリセリル、トリ(ミンク脂肪酸/パルミチン酸)グリセリル、トリ(リシノレイン酸/カプロン酸/カプリル酸/カプリン酸)グリセリル等が挙げられ、化粧品,医薬品用原料として市販されているものを利用することができる。本発明においては、これらより1種又は2種以上を選択して用いる。本発明の効果の点から、トリ(パーム油脂肪酸/パーム核油脂肪酸/オリーブ油脂肪酸/マカデミアナッツ油脂肪酸/アブラナ種子油脂肪酸)グリセリルを用いることが最も好ましい。 Examples of the fatty acid triglyceride used in the present invention include glyceryl triacetylhydroxystearate, glyceryl triacetylricinoleate, glyceryl triisostearate, glyceryl triundecanoate, glyceryl trihydroxystearate, glyceryl tri-2-ethylhexanoate, and glyceryl trioleate. , Glyceryl tri (capryl, caprine, isostearin, adipic acid), glyceryl tri (caprylic acid, capric acid), glyceryl tri (capryl, caprin, myristine, stearic acid), glyceryl tri (capryl, caprin, lauric acid), tri ( Capryl, Caprin, Linoleic acid) Glyceryl, Tricaprylate glyceryl, Tricaprylate glyceryl, Tri beef tallow fatty acid glyceryl, Tri (beef tallow fatty acid, mink oil fatty acid, cod liver oil Fatty acid) glyceryl, glyceryl tristearate, glyceryl tripalmitate, glyceryl tri-2-heptylundecanoate, glyceryl tribehenate, glyceryl trimyristate, glyceryl tri (mink oil fatty acid / palmitic acid), triglyceride fatty acid glyceryl, glyceryl trilaurate , Trilanolin fatty acid glyceryl, tri (ricinolein, capron, capryl, capric acid) glyceryl, trilinoleic acid glyceryl, hydrogenated tri fatty acid (C12-18) glyceryl, (hydrogenated rosin / diisostearic acid) glyceryl, tri (caprylic acid / caprin) Acid / stearic acid) glyceryl, tri (caprylic acid / capric acid / myristic acid / stearic acid) glyceryl, tri (caprylic acid / capric acid / lauric acid) glyceryl, tri (caprylic acid / Capric acid / linoleic acid) glyceryl, tri fatty acid (C10-18) glyceryl, tri fatty acid (C12-18) glyceryl, tri fatty acid (C12-20) glyceryl, tri fatty acid (C18-36) glyceryl, tri (palm oil fatty acid / Palm kernel oil fatty acid / olive oil fatty acid / macadamia nut oil fatty acid / rape seed oil fatty acid) glyceryl, tri (castor fatty acid / olive fatty acid) glyceryl, tri-branched fatty acid (C10-40) glyceryl, tri-branched fatty acid (C12-31) glyceryl, tri (Behenic acid / isostearic acid / eicosandioic acid) glyceryl, tri (mink fatty acid / palmitic acid) glyceryl, tri (ricinoleic acid / caproic acid / caprylic acid / capric acid) glyceryl Has been It is possible to use things. In the present invention, one or more of these are selected and used. From the viewpoint of the effect of the present invention, it is most preferable to use glyceryl tri (palm oil fatty acid / palm kernel oil fatty acid / olive oil fatty acid / macadamia nut oil fatty acid / rape seed oil fatty acid).
スクワランは、2,6,10,15,19,23-ヘキサメチルテトラコサンで、市販の化粧品,医薬品用原料を利用できるが、深海鮫の肝臓及びオリーブの果実から抽出されるスクワレンに水素添加して得られるものが好ましく使用できる。 Squalane is 2,6,10,15,19,23-hexamethyltetracosane, and commercial cosmetics and pharmaceutical raw materials can be used, but hydrogen is added to squalene extracted from the deep-sea shark liver and olive fruit. Can be preferably used.
ミツロウは、トウヨウバチ(Apis indica Radoszkowski),ヨーロッパミツバチ(Apis mellifera L.)等のミツバチの分泌物で、蜜を除いた巣を煮沸して分離した粗ロウ分を化学的に、又は日光により精製漂白して製造される。本発明においては、化粧品,医薬品用原料として市販されている脱臭,精製品もしくは超精製品を用いることが好ましい。 Beeswax is a secreted bee such as Apis indica Radoszkowski, Apis mellifera L., etc., and the crude wax separated by boiling the nest without the nectar is purified or bleached by sunlight. Manufactured. In the present invention, it is preferable to use a deodorized, refined product or a super refined product that is commercially available as a raw material for cosmetics and pharmaceuticals.
ホホバ油は、ホホバ(Simmondsia chinensis 又はSimmondsia californica Nuttall)の種子から抽出される液状のロウである。化粧品,医薬品用原料として市販されているものを用いることができる。 Jojoba oil is a liquid wax extracted from the seeds of jojoba (Simmondsia chinensis or Simmondsia californica Nuttall). Commercially available raw materials for cosmetics and pharmaceuticals can be used.
本発明の皮膚外用剤においては、上記した炭素数10〜22の脂肪酸の1種又は2種以上、脂肪酸トリグリセリドの1種又は2種以上、スクワラン、ミツロウ、及びホホバ油を必須の油性成分として含有させる。これらの油性成分全量における配合量及び配合量比は、皮膚外用剤の剤型により適宜定めることができる。 In the external preparation for skin of the present invention, one or more of the aforementioned fatty acids having 10 to 22 carbon atoms, one or more of fatty acid triglycerides, squalane, beeswax, and jojoba oil are contained as essential oil components. Let The blending amount and blending ratio in the total amount of these oily components can be appropriately determined according to the dosage form of the external preparation for skin.
本発明の皮膚外用剤には上述の必須成分の他に、必要に応じて通常皮膚外用剤に配合される、水性成分、油性成分、保湿剤、色素、界面活性剤、紫外線吸収剤、増粘剤、美容成分、香料、高分子物質、防菌防微剤、アルコール類、粉体、スクラブ剤、生体由来成分等を適宜配合することができる。 In addition to the essential components described above, the external preparation for skin of the present invention is usually mixed with an external preparation for skin as needed, an aqueous component, an oily component, a moisturizer, a dye, a surfactant, an ultraviolet absorber, a thickening agent. Agents, cosmetic ingredients, fragrances, polymer substances, antibacterial and antimicrobial agents, alcohols, powders, scrub agents, biogenic ingredients, and the like can be appropriately blended.
以下に本発明の実施例について詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。 Examples of the present invention will be described in detail below, but the technical scope of the present invention is not limited thereto.
[肌理関連因子発現の確認]
肌理関連遺伝子の発現を、下記の手順で確認した。
ヒト表皮角化細胞を3×105個/ウェルとなるように6ウェルプレートに播種し、5%FBSを含むDMEM培地にて一晩培養した。水酸化レシチンを溶解した培地に交換し、37℃、5% CO2インキュベーター内で24時間培養した。細胞からのTotal RNA抽出はTrizol reagentを用い、ライフテクノロジーズ社のプロトコールに従って調製した。cDNA合成後に下記表1〜3プライマーを使用してリアルタイムPCRにより遺伝子発現を確認した。内部標準として下記表3のGAPDHを使用した。また、水酸化レシチンの培地への添加量は、単独の添加で細胞毒性を示さない濃度を添加量とした。またコントロールとして、水酸化レシチン無添加の培地で同様の実験を行い、コントロールの発現量を1とした相対値を算出後、t検定によりコントロールとの有意差の有無を確認し、結果を表1〜3に示した
[Confirmation of expression of skin related factors]
The expression of the texture related genes was confirmed by the following procedure.
Human epidermal keratinocytes were seeded in a 6-well plate at 3 × 10 5 cells / well and cultured overnight in DMEM medium containing 5% FBS. The medium was replaced with a medium in which hydroxylated lecithin was dissolved, and the cells were cultured in a 37 ° C., 5% CO 2 incubator for 24 hours. Total RNA extraction from cells was prepared using Trizol reagent according to the protocol of Life Technologies. After cDNA synthesis, gene expression was confirmed by real-time PCR using the primers shown in Tables 1 to 3 below. GAPDH shown in Table 3 below was used as an internal standard. Moreover, the addition amount to the culture medium of the hydroxylated lecithin was made into the addition amount which does not show cytotoxicity by single addition. As a control, the same experiment was performed in a medium without added lecithin hydroxide, and after calculating a relative value with the expression level of the control being 1, the presence or absence of a significant difference from the control was confirmed by t-test. Shown in ~ 3
表1に示した通り、水酸化レシチンは、表皮のターンオーバーに関連する遺伝子の発現を有意に促進し、表皮ターンオーバー改善効果が期待された。 As shown in Table 1, hydroxylated lecithin significantly promoted the expression of genes related to epidermal turnover, and an effect of improving epidermal turnover was expected.
表2に示した通り、水酸化レシチンは表皮のバリア機能に関連する遺伝子の発現を有意に促進し、表皮バリア機能改善効果が期待された。 As shown in Table 2, hydroxylated lecithin significantly promoted the expression of genes related to the barrier function of the epidermis, and an effect of improving the epidermal barrier function was expected.
表3に示した通り、水酸化レシチンは抗酸化機能に関連する遺伝子の発現を有意に促進し、抗酸化効果が期待された。 As shown in Table 3, hydroxylated lecithin significantly promoted the expression of genes related to the antioxidant function, and an antioxidant effect was expected.
[実施例1] クレンジングクリーム
(1)ステアリン酸 1.60(質量%)
(2)パルミチン酸 1.30
(3)トリ(牛脂脂肪酸・ミンク油脂肪酸・タラ肝油
脂肪酸)グリセリル 3.80
(4)スクワラン 40.00
(5)脱臭精製ミツロウ 6.00
(6)ホホバ油 4.30
(7)セタノール 1.20
(8)酢酸トコフェロール 0.10
(9)グリセリルモノステアリン酸エステル 0.80
(10)1,3−ブチレングリコール 3.00
(11)グリセリン 8.00
(12)L−アルギニン 0.30
(13)パラオキシ安息香酸メチル 0.10
(14)水酸化レシチン 0.05
(15)精製水 全量を100.00とする量
(16)香料 0.10
製法:(1)〜(9)の油相成分を混合,加熱溶解して85℃とする。一方(10)〜(15)の水相成分を混合,溶解して85℃に加熱する。この水相成分に前記油相を徐々に添加して予備乳化した後、ホモミキサーにて均一に乳化し、冷却して40℃にて(16)を添加,混合する。
[Example 1] Cleansing cream (1) Stearic acid 1.60 (mass%)
(2) Palmitic acid 1.30
(3) Avian (beef tallow fatty acid, mink oil fatty acid, cod liver oil
Fatty acid) Glyceryl 3.80
(4) Squalane 40.00
(5) Deodorized and refined beeswax 6.00
(6) Jojoba oil 4.30
(7) Cetanol 1.20
(8) Tocopherol acetate 0.10
(9) Glyceryl monostearate 0.80
(10) 1,3-butylene glycol 3.00
(11) Glycerin 8.00
(12) L-arginine 0.30
(13) Methyl paraoxybenzoate 0.10
(14) Lecithin hydroxide 0.05
(15) Purified water Amount to make the total amount 100.00 (16) Fragrance 0.10
Production method: The oil phase components (1) to (9) are mixed and dissolved by heating to 85 ° C. On the other hand, the water phase components (10) to (15) are mixed, dissolved, and heated to 85 ° C. The oil phase is gradually added to the aqueous phase component and pre-emulsified, and then uniformly emulsified with a homomixer, cooled, and (16) is added and mixed at 40 ° C.
[実施例2] クレンジングローション
(1)エタノール 15.00(質量%)
(2)ポリオキシエチレン(20)ソルビタン
モノラウリン酸エステル 1.50
(3)ポリオキシエチレンポリオキシプロピレン
ブロックポリマー 1.50
(4)イソステアリン酸 0.05
(5)トリ(カプリル・カプリン酸)グリセリル 0.05
(6)スクワラン 0.10
(7)ホホバ油 0.10
(8)脱臭精製ミツロウ 0.01
(9)パラオキシ安息香酸メチル 0.10
(10)香料 0.05
(11)グリセリン 5.00
(12)1,3−ブチレングリコール 10.00
(13)クエン酸ナトリウム 0.01
(14)水酸化レシチン 0.02
(15)精製水 全量を100.00とする量
製法:(1)に(2)〜(10)を混合,溶解してエタノール相とする。一方、(11)〜(15)を混合,溶解して水相とし、この水相に前記エタノール相を添加して可溶化する。
[Example 2] Cleansing lotion (1) Ethanol 15.00 (mass%)
(2) Polyoxyethylene (20) sorbitan
Monolaurate 1.50
(3) Polyoxyethylene polyoxypropylene
Block polymer 1.50
(4) Isostearic acid 0.05
(5) Tri (capryl / capric acid) glyceryl 0.05
(6) Squalane 0.10
(7) Jojoba oil 0.10
(8) Deodorized and refined beeswax 0.01
(9) Methyl paraoxybenzoate 0.10
(10) Fragrance 0.05
(11) Glycerin 5.00
(12) 1,3-butylene glycol 10.00
(13) Sodium citrate 0.01
(14) Lecithin hydroxide 0.02
(15) Purified water Mass production method with a total volume of 100.00: Mix and dissolve (2) to (10) in (1) to make the ethanol phase. On the other hand, (11) to (15) are mixed and dissolved to form an aqueous phase, and the ethanol phase is added to the aqueous phase to solubilize.
[実施例3] クレンジングフォーム
(1)ステアリン酸 10.00(質量%)
(2)パルミチン酸 10.00
(3)ミリスチン酸 12.00
(4)ラウリン酸 4.00
(5)トリウンデカン酸グリセリル 0.30
(6)スクワラン 1.00
(7)脱臭精製ミツロウ 0.20
(8)ホホバ油 2.00
(9)ポリエチレングリコール (平均分子量1,500) 10.00
(10)グリセリン 15.00
(11)水酸化カリウム 6.00
(12)パラオキシ安息香酸メチル 0.10
(13)水酸化レシチン 0.05
(14)精製水 全量を100.00とする量
(15)グリセリルモノステアリン酸エステル 2.00
(16)ポリオキシエチレン(20)ソルビタン
モノステアリン酸エステル 2.00
(17)香料 0.10
製法:(1)〜(10)を混合,加熱溶解して70℃とする。(11)〜(13)を(14)に溶解し、前記油相を撹拌しながら添加して、十分に中和反応を行わせる。次いで(15),(16)を添加した後、冷却して40℃にて(17)を、添加,混合する。
[Example 3] Cleansing foam (1) Stearic acid 10.00 (mass%)
(2) Palmitic acid 10.00
(3) Myristic acid 12.00
(4) Lauric acid 4.00
(5) Glyceryl triundecanoate 0.30
(6) Squalane 1.00
(7) Deodorized and refined beeswax 0.20
(8) Jojoba oil 2.00
(9) Polyethylene glycol (average molecular weight 1,500) 10.00
(10) Glycerin 15.00
(11) Potassium hydroxide 6.00
(12) Methyl paraoxybenzoate 0.10
(13) Hydroxy lecithin 0.05
(14) Purified water Amount to make the total amount 100.00 (15) Glyceryl monostearate 2.00
(16) Polyoxyethylene (20) sorbitan
Monostearate 2.00
(17) Fragrance 0.10
Production method: (1) to (10) are mixed and dissolved by heating to 70 ° C. (11) to (13) are dissolved in (14), and the oil phase is added with stirring to allow a sufficient neutralization reaction. Next, (15) and (16) are added, and after cooling, (17) is added and mixed at 40 ° C.
[実施例4] 化粧水
(1)エタノール 10.00(質量%)
(2)ポリオキシエチレン(20)ソルビタン
モノラウリン酸エステル 1.50
(3)ウンデシレン酸 0.05
(4)トリイソステアリン酸グリセリル 0.05
(5)スクワラン 0.10
(6)脱臭精製ミツロウ 0.02
(7)ホホバ油 0.10
(8)パラオキシ安息香酸メチル 0.10
(9)香料 0.05
(10)1,3−ブチレングリコール 6.00
(11)グリセリン 4.00
(12)水酸化レシチン 0.10
(13)精製水 全量を100.00とする量
製法:(1)に(2)〜(9)を混合,溶解し、エタノール相とする。一方、(10)〜(13)を均一に混合,溶解して水相とする。この水相に前記エタノール相を添加して、均一に混合する。
[Example 4] Lotion (1) Ethanol 10.00 (mass%)
(2) Polyoxyethylene (20) sorbitan monolaurate 1.50
(3) Undecylenic acid 0.05
(4) Glyceryl triisostearate 0.05
(5) Squalane 0.10
(6) Deodorized and refined beeswax 0.02
(7) Jojoba oil 0.10
(8) Methyl paraoxybenzoate 0.10
(9) Fragrance 0.05
(10) 1,3-butylene glycol 6.00
(11) Glycerin 4.00
(12) Lecithin hydroxide 0.10
(13) Purified water Mass production method with a total amount of 100.00: (2) to (9) are mixed and dissolved in (1) to make the ethanol phase. On the other hand, (10) to (13) are uniformly mixed and dissolved to obtain an aqueous phase. The ethanol phase is added to the aqueous phase and mixed uniformly.
[実施例5] 乳液
(1)ステアリン酸 2.70(質量%)
(2)トリヤシ油脂肪酸グリセリル 1.50
(3)スクワラン 3.00
(4)脱臭精製ミツロウ 2.00
(5)ホホバ油 2.00
(6)セタノール 1.00
(7)グリセリン 5.00
(8)L−アルギニン 0.40
(9)N−ステアロイルグルタミン酸モノナトリウム 0.30
(10)水酸化レシチン 0.20
(11)精製水 全量を100.00とする量
(12)エタノール 4.00
(13)パラオキシ安息香酸メチル 0.10
(14)香料 0.10
製法:(1)〜(6)の油相成分を混合し、加熱溶解して75℃とする。一方、(7)〜(11)の水相成分を混合,溶解して75℃とする。これに前記油相を加えてホモミキサーにて乳化した後冷却し、40℃で(12)〜(14)を添加,混合する。
Example 5 Emulsion (1) Stearic acid 2.70 (mass%)
(2) Tricoconut oil fatty acid glyceryl 1.50
(3) Squalane 3.00
(4) Deodorized and refined beeswax 2.00
(5) Jojoba oil 2.00
(6) Cetanol 1.00
(7) Glycerin 5.00
(8) L-arginine 0.40
(9) Monosodium N-stearoyl glutamate 0.30
(10) Lecithin hydroxide 0.20
(11) Purified water Amount to make the total amount 100.00 (12) Ethanol 4.00
(13) Methyl paraoxybenzoate 0.10
(14) Fragrance 0.10
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating to 75 ° C. On the other hand, the aqueous phase components (7) to (11) are mixed and dissolved to 75 ° C. The oil phase is added thereto, emulsified with a homomixer, cooled, and (12) to (14) are added and mixed at 40 ° C.
[実施例6] クリーム
(1)ステアリン酸 3.00(質量%)
(2)トリ(パーム油脂肪酸/パーム核油脂肪酸/
オリーブ油脂肪酸/マカデミアナッツ油脂肪酸/
アブラナ種子油脂肪酸)グリセリル 7.00
(3)スクワラン 10.00
(4)脱臭精製ミツロウ 2.00
(5)ホホバ油 3.00
(6)セタノール 5.00
(7)プロピレングリコールモノステアリン酸 エステル 3.00
(8)ポリオキシエチレン(20)セチルエーテル 3.00
(9)d−δ−トコフェロール 0.15
(10)1,3−ブチレングリコール 5.00
(11)グリセリン 5.00
(12)水酸化カリウム 0.20
(13)水酸化レシチン 0.30
(14)精製水 全量を100.00とする量
(15)香料 0.10
製法:(1)〜(9)の油相成分を混合,加熱溶解し、70℃とする。一方、(10)〜(14)の水相成分を混合,溶解した後70℃に加熱し、これに前記油相を添加して乳化する。冷却後40℃にて(15)を添加,混合する。
[Example 6] Cream (1) Stearic acid 3.00 (mass%)
(2) Bird (Palm oil fatty acid / Palm kernel oil fatty acid /
Olive oil fatty acid / Macadamia nut oil fatty acid /
Oilseed rapeseed fatty acid) Glyceryl 7.00
(3) Squalane 10.00
(4) Deodorized and refined beeswax 2.00
(5) Jojoba oil 3.00
(6) Cetanol 5.00
(7) Propylene glycol monostearic acid ester 3.00
(8) Polyoxyethylene (20) cetyl ether 3.00
(9) d-δ-tocopherol 0.15
(10) 1,3-butylene glycol 5.00
(11) Glycerin 5.00
(12) Potassium hydroxide 0.20
(13) Lecithin hydroxide 0.30
(14) Purified water Amount to make the total amount 100.00 (15) Fragrance 0.10
Production method: The oil phase components (1) to (9) are mixed and dissolved by heating to 70 ° C. On the other hand, the water phase components (10) to (14) are mixed and dissolved, and then heated to 70 ° C., and the oil phase is added thereto to emulsify. After cooling, add (15) at 40 ° C and mix.
[実施例7] パック剤
(1)ポリ酢酸ビニルエマルション 15.00(質量%)
(2)ポリビニルアルコール 10.00
(3)ソルビトール 5.00
(4)ポリエチレングリコール(平均分子量400) 5.00
(5)水酸化レシチン 0.20
(6)精製水 全量を100.00とする量
(7)酸化チタン 5.00
(8)タルク 10.00
(9)エタノール 8.00
(10)イソパルミチン酸 0.20
(11)トリステアリン酸グリセリル 0.25
(12)スクワラン 2.00
(13)脱臭精製ミツロウ 0.05
(14)ホホバ油 2.00
(15)ポリオキシエチレン(20)ソルビタン 1.00
モノステアリン酸エステル
(16)パラオキシ安息香酸メチル 0.10
(17)香料 0.10
製法:(6)に(3)〜(5)を添加後、(7),(8)を分散して70℃に加熱し、次いで(1),(2)を加えて溶解する。(9)に(10)〜(17)を添加,溶解し、前記水相に添加して混合し、冷却する。
[Example 7] Packing agent (1) Polyvinyl acetate emulsion 15.00 (mass%)
(2) Polyvinyl alcohol 10.00
(3) Sorbitol 5.00
(4) Polyethylene glycol (average molecular weight 400) 5.00
(5) Lecithin hydroxide 0.20
(6) Amount of purified water to 100.00 (7) Titanium oxide 5.00
(8) Talc 10.00
(9) Ethanol 8.00
(10) Isopalmitic acid 0.20
(11) Glyceryl tristearate 0.25
(12) Squalane 2.00
(13) Deodorized and refined beeswax 0.05
(14) Jojoba oil 2.00
(15) Polyoxyethylene (20) sorbitan 1.00
Monostearic acid ester (16) Methyl paraoxybenzoate 0.10
(17) Fragrance 0.10
Production method: (3) to (5) are added to (6), (7) and (8) are dispersed and heated to 70 ° C., and then (1) and (2) are added and dissolved. Add (10) to (17) to (9), dissolve, add to the aqueous phase, mix and cool.
[実施例8] 油中水型乳剤
(1)マイクロクリスタリンワックス 1.00(質量%)
(2)ベヘニン酸 2.00
(3)トリラノリン脂肪酸グリセリル 2.00
(4)スクワラン 25.00
(5)脱臭精製ミツロウ 2.00
(6)ホホバ油 5.00
(7)ソルビタンセスキオレイン酸エステル 4.00
(8)ポリオキシエチレン(20)ソルビタン 1.00
モノオレイン酸エステル
(9)プロピレングリコール 7.00
(10)パラオキシ安息香酸メチル 0.10
(11)水酸化レシチン 0.50
(12)精製水 全量を100.00とする量
製法:(1)〜(8)の油相成分を混合して加熱溶解し、70℃とする。一方(9)〜(12)の水相成分を混合,加熱溶解し、70℃とする。この水相を前記油相に加えてホモジナイザーにて乳化し、次いで冷却する。
[Example 8] Water-in-oil emulsion (1) Microcrystalline wax 1.00 (% by mass)
(2) Behenic acid 2.00
(3) Trilanolin fatty acid glyceryl 2.00
(4) Squalane 25.00
(5) Deodorized and refined beeswax 2.00
(6) Jojoba oil 5.00
(7) Sorbitan sesquioleate ester 4.00
(8) Polyoxyethylene (20) sorbitan 1.00
Monooleate (9) Propylene glycol 7.00
(10) Methyl paraoxybenzoate 0.10
(11) Lecithin hydroxide 0.50
(12) Purified water Quantity manufacturing method to make the total amount 100.00: The oil phase components (1) to (8) are mixed and dissolved by heating to 70 ° C. On the other hand, the aqueous phase components (9) to (12) are mixed and dissolved by heating to 70 ° C. This aqueous phase is added to the oil phase, emulsified with a homogenizer, and then cooled.
[使用試験]
実施例1〜6に配合した水酸化レシチンを、水添レシチンに代替した比較例1〜6を調製した。20代〜40代の女性10名を一群として、実施例1〜6、若しくは比較例1〜6を一日2回(実施例1、2、比較例1、2は一日1回)、1カ月連続して使用させた。右頬部位の角質層水分量を使用開始前と、使用後の2回測定した。使用前の水分量を1とした使用後の水分量の平均値を算出し、使用試験結果とし表4に示した。
[Use test]
Comparative Examples 1 to 6 were prepared by substituting the hydrogenated lecithin for the hydroxylated lecithin blended in Examples 1 to 6. 10 women in their 20s to 40s as a group, Examples 1 to 6 or Comparative Examples 1 to 6 twice a day (Examples 1 and 2 and Comparative Examples 1 and 2 once a day), 1 Used continuously for months. The stratum corneum water content in the right cheek region was measured twice before use and after use. The average value of the water content after use with the water content before use as 1 was calculated and shown in Table 4 as the use test results.
表4に記載した通り、実施例使用群においては、比較例使用群より高い水分量増加率を示しており、水酸化レシチンを配合することにより、高い保湿効果を発揮することが示された。 As described in Table 4, the example use group showed a higher moisture content increase rate than the comparative example use group, and it was shown that a high moisturizing effect was exhibited by adding hydroxylated lecithin.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014128848A JP2016008188A (en) | 2014-06-24 | 2014-06-24 | Skin texture improving agent, epidermis turnover improving agent, epidermis barrier function improving agent, antioxidant, and external preparation for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014128848A JP2016008188A (en) | 2014-06-24 | 2014-06-24 | Skin texture improving agent, epidermis turnover improving agent, epidermis barrier function improving agent, antioxidant, and external preparation for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2016008188A true JP2016008188A (en) | 2016-01-18 |
Family
ID=55225999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014128848A Pending JP2016008188A (en) | 2014-06-24 | 2014-06-24 | Skin texture improving agent, epidermis turnover improving agent, epidermis barrier function improving agent, antioxidant, and external preparation for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2016008188A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017100796A1 (en) | 2016-01-19 | 2017-07-20 | Canon Kabushiki Kaisha | Imaging device and control method of this |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06116116A (en) * | 1992-10-07 | 1994-04-26 | Nippon Saafuakutanto Kogyo Kk | Cosmetics |
| JP2002047132A (en) * | 2000-07-28 | 2002-02-12 | Noevir Co Ltd | External preparation for skin |
| JP2006328024A (en) * | 2005-05-30 | 2006-12-07 | Seiren Co Ltd | Skin care preparation |
| JP2009234920A (en) * | 2008-03-25 | 2009-10-15 | Noevir Co Ltd | External preparation for skin |
-
2014
- 2014-06-24 JP JP2014128848A patent/JP2016008188A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06116116A (en) * | 1992-10-07 | 1994-04-26 | Nippon Saafuakutanto Kogyo Kk | Cosmetics |
| JP2002047132A (en) * | 2000-07-28 | 2002-02-12 | Noevir Co Ltd | External preparation for skin |
| JP2006328024A (en) * | 2005-05-30 | 2006-12-07 | Seiren Co Ltd | Skin care preparation |
| JP2009234920A (en) * | 2008-03-25 | 2009-10-15 | Noevir Co Ltd | External preparation for skin |
Non-Patent Citations (5)
| Title |
|---|
| COMFORTING ANTI-WRINKLE LOTION,ID 2149829,MINTEL GNPD[ONLINE],2013年9月,[検索日2018.09.11], JPN6018036757, ISSN: 0003886870 * |
| CREAM,ID 1443398,MINTEL GNPD[ONLINE],2010年11月,[検索日2018.06.20], JPN6018024071, ISSN: 0003886867 * |
| LOOSE POWDER(00),ID 670458,MINTEL GNPD[ONLINE],2007年3月,[検索日2018.09.11], JPN6018036752, ISSN: 0003886868 * |
| NH EYE CREAM EX,ID 339160,MINTEL GNPD[ONLINE],2005年2月,[検索日2018.09.11], JPN6018036755, ISSN: 0003886869 * |
| WRINKLE SMOOTHING EYE CREME,ID 936491,MINTEL GNPD[ONLINE],2008年7月,[検索日2018.09.11], JPN6018036759, ISSN: 0003886871 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017100796A1 (en) | 2016-01-19 | 2017-07-20 | Canon Kabushiki Kaisha | Imaging device and control method of this |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5917043B2 (en) | Skin preparation | |
| JP5083993B2 (en) | Oil-in-water emulsion composition | |
| JP6367399B2 (en) | Polyunsaturated fatty acid-containing composition | |
| JP5709304B2 (en) | Oil-in-water emulsified cosmetic | |
| JP2013006790A (en) | O/w-type emulsion | |
| JP5693245B2 (en) | Topical skin preparation | |
| JP2016060716A (en) | Cloudy cosmetic | |
| WO1995035090A1 (en) | Skin activator having glycosaminoglycan production accelerator activity | |
| JP4970325B2 (en) | Topical skin preparation | |
| JP2010105924A (en) | Skin keratinization-promoting agent | |
| JP2016008188A (en) | Skin texture improving agent, epidermis turnover improving agent, epidermis barrier function improving agent, antioxidant, and external preparation for skin | |
| JP2014198704A (en) | Emulsification composition | |
| JP6752574B2 (en) | Underwater oil type emulsified cosmetic | |
| JP2009137850A (en) | Oil-in-water type emulsion cosmetic | |
| JP6918548B2 (en) | Topical skin or cosmetics | |
| JP2010120860A (en) | Bleaching agent | |
| JP5995453B2 (en) | Cosmetics and method for producing the same | |
| JP2017088526A (en) | 3-o-alkyl glyceryl ascorbic acid and use thereof | |
| US20190247290A1 (en) | Composition containing linoleic acid | |
| JP6001991B2 (en) | Cosmetics | |
| JP2012012320A (en) | Solid lipid emulsion, and skin care external preparation | |
| JP5662750B2 (en) | Water-in-oil emulsion composition | |
| CN110312503B (en) | Oil-in-water emulsion composition | |
| JP6106777B2 (en) | Topical skin preparation | |
| JP4942427B2 (en) | Oil-in-water microemulsion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170317 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180112 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180123 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180131 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180703 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180903 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20181002 |